iopromide has been researched along with Bile Duct Cancer in 6 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the enhancement pattern of hilar cholangiocarcinoma on contrast-enhanced ultrasound (CEUS) with that on contrast-enhanced computed tomography (CECT)." | 1.36 | Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. ( Chen, LD; Lin, MX; Liu, GJ; Lu, MD; Wang, Z; Xie, XH; Xie, XY; Xu, HX; Xu, ZF, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muenzfeld, H | 1 |
| Mahjoub, S | 1 |
| Roehle, R | 1 |
| Pelzer, U | 1 |
| Bahra, M | 1 |
| Boening, G | 1 |
| Hamm, B | 1 |
| Geisel, D | 1 |
| Auer, TA | 1 |
| Kim, HJ | 2 |
| Yu, ES | 1 |
| Byun, JH | 2 |
| Hong, SM | 2 |
| Kim, KW | 2 |
| Lee, JS | 1 |
| Kim, SY | 2 |
| Hong, N | 1 |
| Kim, JH | 1 |
| Xu, HX | 1 |
| Chen, LD | 1 |
| Xie, XY | 1 |
| Xie, XH | 1 |
| Xu, ZF | 1 |
| Liu, GJ | 1 |
| Lin, MX | 1 |
| Wang, Z | 1 |
| Lu, MD | 1 |
| D'Onofrio, M | 1 |
| Vecchiato, F | 1 |
| Cantisani, V | 1 |
| Barbi, E | 1 |
| Passamonti, M | 1 |
| Ricci, P | 1 |
| Malagò, R | 1 |
| Faccioli, N | 1 |
| Zamboni, G | 1 |
| Pozzi Mucelli, R | 1 |
| Vogl, TJ | 1 |
| Balzer, JO | 1 |
| Dette, K | 1 |
| Hintze, R | 1 |
| Pegios, W | 1 |
| Mäurer, J | 1 |
| Keck, H | 1 |
| Neuhaus, P | 1 |
| Felix, R | 1 |
6 other studies available for iopromide and Bile Duct Cancer
| Article | Year |
|---|---|
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Clinical Pr | 2019 |
CT differentiation of mucin-producing cystic neoplasms of the liver from solitary bile duct cysts.
Topics: Adenocarcinoma, Mucinous; Bile Duct Neoplasms; Choledochal Cyst; Contrast Media; Diagnosis, Differen | 2014 |
Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Contrast Media; Female; Humans; Image En | 2015 |
Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Contrast | 2010 |
Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Contrast | 2008 |
Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangiopancreatogr | 1998 |